UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

Rheumatology (Oxford, England), 2012-07, Vol.51 Suppl 5 (suppl 5), p.v3-v11

Choy, Ernest

2012

Volltextzugriff (PDF)

EULAR revised recommendations for the management of fibromyalgia

Annals of the rheumatic diseases, 2017-02, Vol.76 (2), p.318-328

2017

Volltextzugriff (PDF)

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

Annals of the rheumatic diseases, 2008-04, Vol.67 (4), p.536-541

2008

Volltextzugriff (PDF)

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

Annals of the rheumatic diseases, 2009-04, Vol.68 (4), p.460-469

2009

Volltextzugriff (PDF)

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Volltextzugriff (PDF)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2143-2154

2014

Volltextzugriff (PDF)

Fatigue in rheumatoid arthritis reflects pain, not disease activity

Rheumatology (Oxford, England), 2006-07, Vol.45 (7), p.885-889

2006

Volltextzugriff (PDF)

Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

Annals of the rheumatic diseases, 2008-05, Vol.67 (5), p.656-663

2008

Volltextzugriff (PDF)

Functional MRI in rheumatic diseases with a focus on fibromyalgia

Clinical and experimental rheumatology, 2018-09, Vol.36 Suppl 114 (5), p.82

2018

Volltextzugriff (PDF)

Efficacy of a novel PEGylated humanized anti‐TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double‐blinded, randomized, dose‐escalating trial

British journal of rheumatology, 2002-10, Vol.41 (10), p.1133-1137

2002

Volltextzugriff (PDF)

POS0346 THE THERAPEUTIC EFFECTS OF OMEGA-6 PUFA (PINOLENIC ACID) ON THE TRANSCRIPTOMIC PROFILE OF ACTIVATED PERIPHERAL BLOOD MONONUCLEAR CELLS ISOLATED FROM HEALTHY CONTROLS AND RHEUMATOID ARTHRITIS PATIENTS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.402-403

2021

Volltextzugriff (PDF)

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal

Rheumatology (Oxford, England), 2005-11, Vol.44 (11), p.1414-1421

2005

Volltextzugriff (PDF)

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis

Annals of the rheumatic diseases, 2008-06, Vol.67 (6), p.855-859

2008

Volltextzugriff (PDF)

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1015-1021

2010

Volltextzugriff (PDF)

FRI0027 Patient-based disease activity score predicts flare better than improvement – blood test provides insignificant contribution

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.560

2018

Volltextzugriff (PDF)

Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases

Annals of the Rheumatic Diseases, 2009-12, Vol.68 (12), p.1800-1804

2009

Volltextzugriff (PDF)

Treatment of dermatomyositis and polymyositis

British journal of rheumatology, 2002-01, Vol.41 (1), p.7-13

2002

Volltextzugriff (PDF)

The consequences of rheumatoid arthritis: quality of life measures in the individual patient

Clinical and experimental rheumatology, 2005-09, Vol.23 (5 Suppl 39), p.S43

2005

Volltextzugriff (PDF)

Fibromyalgia position paper

Clinical and Experimental Rheumatology, 2021-01, Vol.39 (3), p.186-193

2021

Volltextzugriff (PDF)

A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1288-1293

2005

Volltextzugriff (PDF)

SP0125 Inflammation and cardiovascular disease – relevant metabolic biomarkers

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.31

Choy, E

2017

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1296-1304

2007

Volltextzugriff (PDF)

Psychological factors and their relation to osteoarthritis pain

Osteoarthritis and cartilage, 2010-07, Vol.18 (7), p.883-887

2010

Volltextzugriff (PDF)

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis

Clinical and experimental rheumatology, 2009-05, Vol.27 (3), p.510

Choy, E H

2009

Volltextzugriff (PDF)

Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.807-811

2009

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

ThemaRheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(122)

Sprache

Englisch
(122)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(108)
Science & Technology
(108)
Humans
(97)
Rheumatoid Arthritis
(57)
Biological And Medical Sciences
(52)
Medical Sciences
(50)
Female
(45)
Male
(42)
Middle Aged
(41)
Arthritis, Rheumatoid - Drug Therapy
(36)
Treatment Outcome
(35)
Diseases Of The Osteoarticular System
(34)
Adult
(33)
Aged
(30)
Inflammatory Joint Diseases
(30)
Antirheumatic Agents - Therapeutic Use
(27)
Severity Of Illness Index
(21)
Fibromyalgia
(16)
Pharmacology. Drug Treatments
(15)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

EULAR revised recommendations for the management of fibromyalgia

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Fatigue in rheumatoid arthritis reflects pain, not disease activity

Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis

Functional MRI in rheumatic diseases with a focus on fibromyalgia

Efficacy of a novel PEGylated humanized anti‐TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double‐blinded, randomized, dose‐escalating trial

POS0346 THE THERAPEUTIC EFFECTS OF OMEGA-6 PUFA (PINOLENIC ACID) ON THE TRANSCRIPTOMIC PROFILE OF ACTIVATED PERIPHERAL BLOOD MONONUCLEAR CELLS ISOLATED FROM HEALTHY CONTROLS AND RHEUMATOID ARTHRITIS PATIENTS

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

FRI0027 Patient-based disease activity score predicts flare better than improvement – blood test provides insignificant contribution

Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases

Treatment of dermatomyositis and polymyositis

The consequences of rheumatoid arthritis: quality of life measures in the individual patient

Fibromyalgia position paper

A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs

SP0125 Inflammation and cardiovascular disease – relevant metabolic biomarkers

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

Psychological factors and their relation to osteoarthritis pain

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis

Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis

Aktive Filter

Suchergebnisse filtern